Pancreatic Cancer Research

ResearcherTang Du HospitalActive in the last 2 years

Jianguo Lu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4356-5645; OpenAlex author ID A5103270851. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Icaritin and lenvatinib treatment for unresectable localized progressive pancreatic cancer: a report of six cases. First author DOI 10.1080/07853890.2025.2512436↗
  2. Adrenaline promotes epithelial-to-mesenchymal transition via HuR-TGFβ regulatory axis in pancreatic cancer cells and the implication in cancer prognosis. Last author DOI 10.1016/j.bbrc.2017.09.146↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guixing Jiang · 1 shared paper, 2025 · strength 0.28
  2. Defei Hong · 1 shared paper, 2025 · strength 0.28
  3. Xiaolong Liu · 1 shared paper, 2025 · strength 0.28
  4. Jun Pu · 1 shared paper, 2017 · strength 0.08
  5. Huiwen Luo · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.